Blog

The capital will drive market expansion, fuel product innovation, and enable acquisitions to help energy producers power the AI-driven future.

AUSTIN, TX / ACCESS Newswire / June 25, 2025 / Novi Labs (“Novi”), the AI-first energy analytics platform transforming investment decisions across the energy sector, today announced a $35 million investment from Invictus Growth Partners (“Invictus”), a private equity firm focused on backing category-defining companies leveraging artificial intelligence in high-impact industries. Over $50 billion in annual capital allocation decisions from leading energy institutions and investors flow through Novi’s analytics platform, establishing AI-powered analytics as the new standard for institutional energy investment.

The funding will accelerate Novi’s product roadmap, support go-to-market expansion, and enable targeted acquisitions, solidifying Novi’s role as the core intelligence platform for upstream energy investment.

“This investment marks a defining inflection point in our mission to transform how energy development and capital allocation decisions are made”. said Scott Sherwood, CEO of Novi Labs. “We’re moving the industry beyond intuition-based legacy workflows to a future defined by AI and proprietary data. That shift is becoming even more urgent as the rapid buildout of data centers to power AI drives unprecedented energy demand. Novi is uniquely positioned at the center of this transformation, delivering the intelligence platform energy producers rely on to guide billions in capital decisions.”

Powering the Paradigm Shift in Energy Analytics

Traditional tools are falling short in a sector defined by volatility, scale, and operational complexity. Today’s energy producers, investors, and private equity firms require faster, more accurate, and more transparent insights to inform critical decisions.

Novi Labs delivers the only energy analytics platform built natively in the cloud and architected from day one for AI. The platform combines advanced machine learning, exclusive proprietary datasets, and deep reservoir science to produce decision-grade forecasts, enabling smarter capital deployment, optimized well design, and measurable performance gains.

“As AI drives exponential energy consumption, Novi’s platform enables energy producers to scale efficiently and strategically meet that demand,” said John DeLoche, Managing Partner at Invictus. “With a foundation of deep domain knowledge, proprietary datasets, and scientific precision, Novi is reshaping capital allocation in the energy sector. We believe they have built what will become the standard operating system for energy investment, and we are honored to partner with Scott and the entire Novi team.”

Fueling Scale Through Four Strategic Pillars

The $35 million investment will be deployed across four high-impact initiatives designed to accelerate Novi’s growth and category leadership:

• AI-First Product Development: Expanding Novi’s platform to unlock new predictive modeling, analytics, and investment intelligence capabilities.

• Go-to-Market Execution: Scaling commercialization efforts across strategic geographies, verticals, and customer segments.

• Operational Infrastructure: Investing in infrastructure, systems, and talent to support enterprise-grade performance and exponential growth.

• Strategic M&A: With fresh capital and strategic backing, Novi is poised to absorb complementary technology, research, and data players, unlocking new synergies and accelerating innovation.

From Disruption to Domination

As the energy sector faces rising volatility, surging AI-driven demand, and capital constraints across oil & gas, power generation, and renewable energy markets, Novi is uniquely positioned to lead the next era of energy investment intelligence:

• AI That Understands Energy: Domain-specific models trained on proprietary data, not retrofitted to legacy frameworks.

• Energy Data Others Can’t Get: Exclusive proprietary datasets and advanced research methodologies create defensible data moats.

• Research That Shows the Receipts: Proprietary data powers data-driven research that delivers both insights and downloadable underlying datasets to clients, replacing industry guesswork with verifiable intelligence.

About Novi Labs

Novi Labs is the leading AI-first energy analytics platform redefining how energy operators and investors make high-stakes capital decisions. Built on proprietary machine learning, exclusive datasets, and deep reservoir expertise, Novi delivers the industry’s most accurate well-level forecasts and development insights. Many leading E&P operators and mineral owners rely on Novi, with billions in monthly capital decisions flowing through the platform. Novi is headquartered in Austin, Texas.
www.novilabs.com

About Invictus Growth Partners

Invictus Growth Partners is a buyout and growth equity firm that invests in outstanding, bootstrapped, capital-efficient, automation-enabled cloud software, cybersecurity, and fintech companies. The firm is dedicated to supporting companies seeking capital and strategic resources to accelerate their growth.
www.invictusgrowth.com

SOURCE: Novi Labs

View the original press release on ACCESS Newswire

MIAMI, FL / ACCESS Newswire / June 25, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) (“MIRA” or the “Company”), a clinical-stage pharmaceutical company focused on developing novel therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced new in vitro preclinical data generated by Eurofins supporting the therapeutic potential of SKNY-1, a next-generation oral drug candidate being developed by SKNY Pharmaceuticals, Inc. (“SKNY”). MIRA has signed a definitive agreement to acquire SKNY, and the proposed transaction remains subject to regulatory review and shareholder approval.

SKNY-1 is being developed to help individuals lose weight and quit smoking by targeting key biological pathways involved in appetite, addiction, and reward-without triggering the central nervous system (CNS) side effects that have historically limited cannabinoid-based therapies.

“We believe SKNY-1 could be a first-in-class oral therapy for two of the largest and most underserved markets: obesity and nicotine addiction,” said Erez Aminov, CEO of MIRA. “What makes this drug candidate so exciting is its precision-it’s engineered to avoid the psychiatric side effects that doomed earlier drugs in this class, while offering a safe, convenient, once-daily oral option.”

Designed for Selectivity and Safety
Previous CB1-targeting drugs, such as rimonabant (Acomplia®, Sanofi), showed weight loss and metabolic results but were ultimately withdrawn from the market due to serious psychiatric side effects, including depression and suicidal ideation.¹ These effects stemmed from non-selective inhibition of CB1 signaling in the brain.

In contrast, in vitro studies conducted by Eurofins demonstrated that SKNY-1 acts as a biased CB1 modulator-selectively blocking the β-arrestin signaling pathway, which is associated with cravings and compulsive behavior, while preserving G-protein signaling, which is important for emotional and cognitive stability. This selective mechanism is designed to reduce cravings and body weight without disrupting mood.

A Dual Receptor Strategy-Engaging CB2 for Metabolic Support
In addition to CB1 modulation, SKNY-1 also interacts with the CB2 receptor, which plays a critical role in metabolic regulation and inflammation. Eurofins’ in vitro data show that SKNY-1 behaves as a partial CB2 agonist, potentially enhancing fat metabolism, reducing peripheral inflammation and improving insulin sensitivity. This dose-dependent flexibility distinguishes SKNY-1 from earlier CB1-only drugs and may enable a broader therapeutic impact on obesity-related pathways.

“SKNY-1 combines modern pharmacology with real-world practicality,” said Dr. Itzchak Angel, Chief Scientific Advisor at MIRA. “By precisely modulating CB1 and CB2 and supporting dopamine stability, it targets obesity and addiction through multiple, complementary mechanisms while potentially avoiding cannabinoid-related psychiatric side-effects.”

Dopamine Stability Without Stimulant Risk
SKNY-1 also mildly inhibits the MAO-B enzyme, helping regulate dopamine, a neurotransmitter involved in motivation, focus, and reward. Unlike older monoamine inhibitors, SKNY-1 does not inhibit MAO-A, reducing the risk of serotonin-related side effects. Importantly, the compound demonstrated no or minimal antagonist binding to dopamine receptors (D1, D2, D3), further supporting its favorable CNS safety profile.

A Differentiated Alternative to Injectables
While injectable GLP-1 drugs have gained market attention, they are often associated with gastrointestinal side effects and muscle loss. SKNY-1 is being developed as an oral therapy with a profile and expected mechanism that may help preserve muscle mass and improve patient adherence by avoiding injections.

Market Outlook and Strategic Fit
Obesity and smoking remain two of the world’s leading causes of preventable death. The global obesity drug market is projected to surpass $150 billion in value by 2030, and the U.S. smoking cessation market is forecast to grow from $28 billion in 2024 to over $50 billion by decade’s end.

Pending the completion of the proposed acquisition, MIRA believes SKNY-1 could become a cornerstone asset within its pipeline, offering a next-generation solution to two major health challenges. The Company is currently finalizing animal data related to weight loss and nicotine addiction, which will further support its development strategy and future regulatory filings.

MIRA has submitted the required regulatory filings to the U.S. Securities and Exchange Commission (SEC) in connection with the proposed acquisition of SKNY. A shareholder vote will follow in accordance with SEC regulations.

For more information, please visit: www.mirapharmaceuticals.com

About MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for neurologic, neuropsychiatric, and metabolic disorders. The Company’s pipeline includes oral drug candidates designed to address significant unmet medical needs in areas such as anxiety, cognitive decline, neuropathic pain, obesity, and addiction.

Cautionary Note Regarding Forward-Looking Statements
This press release and the statements of MIRA’s management related thereto contain “forward-looking statements,” which are statements other than historical facts made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may be identified by words such as “aims,” “anticipates,” “believes,” “could,” “estimates,” “expects,” “forecasts,” “goal,” “intends,” “may,” “plans,” “possible,” “potential,” “seeks,” “will,” and variations of these words or similar expressions that are intended to identify forward-looking statements. Any statements in this press release that are not historical facts may be deemed forward-looking. Any forward-looking statements in this press release are based on MIRA’s current expectations, estimates, and projections only as of the date of this release and are subject to a number of risks and uncertainties (many of which are beyond MIRA’s control) that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements, including related to MIRA’s potential merger with SKNY Pharmaceuticals, Inc. These and other risks concerning MIRA’s programs and operations are described in additional detail in the Annual Report on Form 10-K for the year ended December 31, 2024, and the Form 14A filed by MIRA on June 18, 2025, and other SEC filings, which are on file with the SEC at www.sec.gov and MIRA’s website at https://www.mirapharmaceuticals.com/investors/sec-filings. MIRA explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.

Footnote:
¹ European Medicines Agency. “Acomplia Suspended as Risks Outweigh Benefits.” October 23, 2008.

CONTACT:
Helga Moya
info@mirapharma.com
(786) 432-9792

SOURCE: MIRA Pharmaceuticals

View the original press release on ACCESS Newswire

Tax Identity Theft on the Rise in 2025 – Clear Start Tax Urges Victims to Act Quickly to Limit IRS Damage

IRVINE, CA / ACCESS Newswire / June 25, 2025 / Even after the April 15 deadline, tax identity theft continues to spike in 2025. Clear Start Tax is warning taxpayers to stay alert for one of the most damaging forms of IRS fraud: discovering that someone else has already filed a return in your name. Left unaddressed, this growing issue can delay refunds, trigger audits, and cause years of financial headaches.

The IRS has already flagged a surge in suspicious early-season filings, often from criminals using stolen personal information to claim refunds fraudulently. Unfortunately, many victims don’t realize what has happened until they attempt to file and receive a rejection stating that their return has “already been filed.”

“It’s one of the most stressful tax situations a person can face,” said the Head of Client Solutions at Clear Start Tax. “You’re locked out of your own account, refunds are frozen, and the IRS clock doesn’t stop. But with the right steps, you can regain control.”

Signs Someone Else Filed Using Your Information

If someone uses your Social Security Number to file a tax return, the IRS may process the fraudulent return before you even realize it. Clear Start Tax says to watch for the following red flags:

• Your e-filed return is rejected because a return was already submitted using your SSN.

• The IRS says a refund was issued, but you haven’t filed, and didn’t receive the funds.

• The IRS sends a notice about a suspicious return, new account activity, or a balance due from an unfamiliar filing.

• Your IRS account shows filings or income you don’t recognize.

Tax identity theft can leave you responsible for balances or penalties you didn’t cause. To protect yourself and explore your options under the IRS Fresh Start Program, answer a few quick questions and take the first step toward resolution.

What To Do If You Suspect Tax Identity Theft

The IRS has a formal process for victims of identity theft, but fast action is critical. Clear Start Tax outlines the steps you should take right away if you think someone has filed a return using your Social Security number:

1. File IRS Form 14039 (Identity Theft Affidavit) immediately to alert the IRS of suspected fraud.

2. Respond to any IRS notices – do not ignore them, even if they reference a return you didn’t file.

3. Request a copy of the fraudulent return by submitting Form 4506-F for further investigation.

4. File your real return by paper (not e-file) and include all required identity verification documents.

Clear Start Tax adds that many victims fail to respond quickly enough, which can delay the resolution process or lead to enforced balances for tax debt they don’t actually owe.

How Clear Start Tax Helps Identity Theft Victims

Tax identity theft cases can be difficult to navigate without expert help, especially when IRS systems continue to flag your account. Clear Start Tax supports affected clients by handling the entire response process:

• Managing all IRS correspondence

• Filing Forms 14039 and 4506-F

• Correcting account records and securing account transcripts

• Rebuilding compliance and applying for appropriate taxpayer protections

“We’ve helped clients who were wrongly pursued for years because of identity theft,” said the Head of Client Solutions at Clear Start Tax. “The key is fast documentation, clean records, and expert follow-through – especially when the IRS system flags your account.”

Don’t Wait for the IRS to Sort It Out

Identity theft cases can take months or even years to fully resolve, especially when there’s overlap with back taxes, unfiled returns, or penalties. Victims who act quickly, keep clear documentation, and work with experienced professionals are more likely to avoid long-term damage.

About Clear Start Tax

Clear Start Tax is a full-service tax liability resolution firm that serves taxpayers throughout the United States. The company specializes in assisting individuals and businesses with a wide range of IRS and state tax issues, including back taxes, wage garnishment relief, IRS appeals, and offers in compromise. Clear Start Tax helps taxpayers apply for the IRS Fresh Start Program, providing expert guidance in tax resolution. Fully accredited and A+ rated by the Better Business Bureau, the firm’s unique approach and commitment to long-term client success distinguish it as a leader in the tax resolution industry.

Need Help With Back Taxes?

Click the link below:
https://clearstarttax.com/qualifytoday/

(888) 710-3533

Contact Information

Clear Start Tax
Corporate Communications Department
seo@clearstarttax.com
(949) 535-1627

SOURCE: Clear Start Tax

View the original press release on ACCESS Newswire

Recognized for revolutionizing large file transfer and management workflows in sports, news, and high-volume media production

OTTAWA, ON / ACCESS Newswire / June 25, 2025 / MASV (massive.io), the fastest and most reliable large file transfer platform for media professionals, has been named an IDC Innovator in the IDC Innovators: Media and Entertainment, 2025 report (doc #US52275525, May 2025).

“In today’s market, delivering high-value workflow efficiencies and measurable ROI is essential,” said Alex Holtz, Research Director, Worldwide Media & Entertainment Digital Strategies at IDC. “MASV offers a unique combination of deep cloud and tool integrations, exceptional ease of use, and faster implementation with minimal setup complexity. Their flexible pricing model and ability to work within existing infrastructures further reduce customer risk-making MASV an IDC Innovator in the space.“

According to the report, “MASV serves modern media and entertainment companies with data-intensive applications such as sports and news. Sports demands quick and reliable delivery of high-quality video content from live event footage to highlight reels. Benefits include real-time delivery, efficient remote uploads, and reliability. News agencies constantly operate under immense time constraints, needing to gather and organize breaking stories at lightning speed. Journalists can efficiently upload footage from the field, which MASV automatically categorizes for streamlined newsroom workflows. Reporters with minimal technical expertise can transfer files quickly using drag-and-drop functionality, avoiding technical delays. Automated workflows, such as integrations with Amazon S3 and Slack notifications, ensure that producers and editors access content instantly, accelerating broadcast readiness for time-sensitive stories. MASV simplifies, manages, and supports the transfer of entire archives, individual files up to 15TB, or multi-petabyte data sets such as historical footage or production backups. MASV offers cloud-based scalability with platforms that enable seamless ingestion and distribution of petabyte-scale data directly into storage systems and provides secure, reliable transfers.”

“We’re honored to be recognized as an IDC Innovator in media and entertainment,” said MASV CTO and interim CEO Majed Alhajry. “We’ve built MASV to solve the real problems media teams face today, from shrinking timelines to distributed production teams, and this recognition validates the mission we’re on.”

Download the IDC Innovators Excerpt
To view the MASV excerpt from the IDC Innovators: Media and Entertainment, 2025 report, visit https://massive.io/masv-idc-innovator.

About IDC Innovators:

An IDC Innovators report presents a set of vendors – under $100M in annual revenue at the time of selection – chosen by an IDC analyst within a specific market that offer a new technology, a groundbreaking solution to an existing issue, and/or an innovative business model. It is not an exhaustive evaluation or a comparative ranking of all companies, but rather a document that highlights innovative companies in a specific market segment. IDC INNOVATOR and IDC INNOVATORS are trademarks of International Data Group, Inc.

About MASV

MASV is a cloud-based large file transfer platform designed to orchestrate and secure file movement worldwide to meet fast-paced and nimble workflows. Global media organizations rely on MASV to automatically deliver their large files without any restrictions, allowing them to concentrate on their next big deliverable. To learn more and try MASV for free, visit massive.io or contact team@masv.io.

MASV Press Contact:

Melissa Harding
Grithaus Agency
(e) melissa@grithaus.agency

###

SOURCE: MASV

View the original press release on ACCESS Newswire

New Central Virginia campus expands EdgeCore’s Virginia data center portfolio to over 1.6GW

DENVER, CO / ACCESS Newswire / June 25, 2025 / EdgeCore Digital Infrastructure, a wholesale data center developer, owner, and operator, announced the purchase of 697 acres of land in the Shannon Hill Regional Business Park in Louisa County, Virginia, and plans to develop a 3.9 million square foot high-density data center campus capable of supporting over 1.1 gigawatts of power.

“EdgeCore was deliberate and intentional in our decision to commit to Louisa County for the development of a 1.1+ GW high-density data center campus,” said Lee Kestler, CEO, EdgeCore Digital Infrastructure. “The investment in this land enables EdgeCore to expand our growth in Central Virgina, providing our hyperscale and AI focused customers with scalable, cost-efficient data center solutions, while simultaneously benefitting the residents of Louisa County with decades of tax revenue, job creation and ancillary investments. I want to thank the Louisa County Industrial Development Authority and the Commonwealth’s economic development team for their support.”

“Virginia is the world capital for the infrastructure on which the internet and the entire global economy runs. From the spine of the internet running through Ashburn to the transatlantic cables that connect in Virginia Beach, the entire Commonwealth is engaged in supporting the technology which runs the world. We are proud to welcome EdgeCore to Central Virginia where their $17 billion investment will create jobs and fund vital public resources,” said Governor Glenn Youngkin.

“REC and our affiliate, Hyperscale Energy, are proud to support EdgeCore’s significant investment in Louisa County. Their vision aligns with the growing demands of the digital economy, and we’re honored they chose our service area for this major development,” said John Hewa, CEO, Rappahannock Electric Cooperative. “As a cooperative committed to delivering world-class service to our data center members, we look forward to working alongside EdgeCore and Louisa County to power this project and build the infrastructure that enables its success.”

As EdgeCore has done with its data center campuses in other markets, the company will employ its community-first approach in Louisa County. Residents can expect EdgeCore’s development to generate economic growth and jobs, as well as to have minimal impact on local water supplies and the surrounding Central Virginia landscape. EdgeCore will leverage best practices honed in Greater Phoenix and other markets to minimize traffic during construction, and respond quickly to questions raised by community members.

“In my role as EdgeCore’s head of community and government relations, I lean heavily on my 25 years of experience in economic development to ensure that the communities in which we do business see EdgeCore as a resource and a partner,” said William Jabjiniak, SVP, National Community/Government Relations, EdgeCore Digital Infrastructure. “In Louisa County, we intend to contribute as a good neighbor would by investing our time and resources to the betterment of the county at large.”

To ensure EdgeCore’s campus makes the most efficient use of water possible, the company will employ a close-looped air-cooled system at its Louisa County campus that uses very little water to cool its facilities, carrying a benchmark water usage effectiveness (WUE) rating below .01 L/kWh.

Today’s new market announcement about Louisa County brings EdgeCore’s total active market count to six, including Ashburn, Culpeper, VA, Silicon Valley, Greater Phoenix and Reno, all of which have been designed to accommodate data centers for single hyperscale tenants.

About EdgeCore Digital Infrastructure

EdgeCore Digital Infrastructure serves the world’s largest cloud and internet companies with both ready-for-occupancy and build-to-suit data center campuses that are designed for density. Privately held and backed by committed equity, EdgeCore enables hyperscale customer requirements by proactively investing in regions that provide the land and power necessary to support and scale AI and cloud technology. While working thoughtfully with the communities in which we do business, our data center campuses are built at scale to meet key performance specifications, safety metrics and sustainability objectives. EdgeCore has data center campuses in six North American markets with plans to continue regional expansion in 2025 and beyond. For more information, please visit edgecore.com.

Media Contact
Courtney Gaudet
EdgeCore Digital Infrastructure
courtney.gaudet@edgecore.com

SOURCE: EdgeCore Digital Infrastructure

View the original press release on ACCESS Newswire

Reverse Split Becomes Effective Friday, June 27, 2025

Shareholder- and Board-Approved Action Reduces Shares Outstanding to 1.4 million from 13.9 million, Expected to Ensure Continued Compliance with Nasdaq Listing Requirements

AUSTIN, TEXAS / ACCESS Newswire / June 25, 2025 / Interactive Strength Inc. (Nasdaq:TRNR) (“TRNR” or “the Company”), maker of innovative specialty fitness equipment under the CLMBR and FORME brands and pending acquirer of Sportstech and Wattbike, today announced that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10. The reverse stock split will become effective on June 27, 2025, and the Company’s common stock will begin trading on a post-split basis at the market open on June 27, 2025, under the Company’s existing trading symbol “TRNR”, with the new CUSIP number, 45840Y401. The reverse stock split is part of the Company’s plan to maintain compliance with the minimum bid price requirement of $1.00 per share required to maintain continued listing on The Nasdaq Capital Market, among other benefits.

The reverse stock split range was approved by the Company’s stockholders at the Company’s Special Meeting of Stockholders held on March 11, 2025, at the discretion of the Company’s Board of Directors. The final ratio was approved by the Company’s Board on May 6, 2025.

The reverse stock split is expected to reduce the number of shares of the Company’s outstanding common stock to approximately 1.4 million shares from approximately 13.9 million shares. As a result of the reverse stock split, proportionate adjustments will be made to the number of shares of the Company’s common stock underlying the Company’s outstanding preferred stock, equity awards and warrants and the number of shares issuable under the Company’s equity incentive plans and other existing agreements, as well as the conversion or exercise price, as applicable. There will be no change to the number of authorized shares or the par value per share of the Company’s common stock.

Information for TRNR Stockholders

As a result of the reverse stock split, every ten pre-split shares of common stock outstanding will become one share of common stock. The Company’s transfer agent, Equiniti Trust Company, LLC, will serve as the exchange agent for the reverse stock split.

Registered stockholders holding pre-split shares of the Company’s common stock electronically in book-entry form are not required to take any action to receive post-split shares. Those stockholders who hold their shares in brokerage accounts or in “street name” will have their positions automatically adjusted to reflect the reverse stock split, subject to each broker’s particular processes, and will not be required to take any action in connection with the reverse stock split.

Stockholders holding shares of the Company’s common stock in certificate form will have their holdings of the Company’s common stock automatically adjusted to reflect the reverse stock split.

No fractional shares will be issued in connection with the reverse stock split. Stockholders who otherwise would be entitled to receive fractional shares will receive cash for each fraction of a share they hold.

TRNR Investor Contact

ir@interactivestrength.com

About Interactive Strength Inc.:

Interactive Strength Inc. produces innovative specialty fitness equipment and digital fitness services under two main brands: 1) CLMBR and 2) FORME. Interactive Strength Inc. is listed on Nasdaq (symbol:TRNR).

CLMBR is a vertical climbing machine that offers an efficient and effective full-body strength and cardio workout. CLMBR’s design is compact and easy to move – making it perfect for commercial or in-home use. With its low impact and ergonomic movement, CLMBR is safe for most ages and levels of ability and can be found at gyms and fitness studios, hotels, and physical therapy facilities, as well as available for consumers at home. www.clmbr.com.

FORME is a digital fitness platform that combines premium smart gyms with live virtual personal training and coaching to deliver an immersive experience and better outcomes for both consumers and trainers. FORME delivers an immersive and dynamic fitness experience through two connected hardware products: 1) The FORME Studio Lift (fitness mirror and cable-based digital resistance) and 2) The FORME Studio (fitness mirror). In addition to the company’s connected fitness hardware products, FORME offers expert personal training and health coaching in different formats and price points through Video On-Demand, Custom Training, and Live 1:1 virtual personal training. www.formelife.com.

Forward Looking Statements:

This press release includes certain statements that are “forward-looking statements” for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements do not relate strictly to historical or current facts and reflect management’s assumptions, views, plans, objectives and projections about the future. Forward-looking statements generally are accompanied by words such as “believe”, “project”, “expect”, “anticipate”, “estimate”, “intend”, “strategy”, “future”, “opportunity”, “plan”, “may”, “should”, “will”, “would”, “will be”, “will continue”, “will likely result” or similar expressions that predict or indicate future events or trends or that are not statements of historical matters. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of the Company. Risks and uncertainties include but are not limited to: our ability to regain compliance with Nasdaq’s continued listing requirements; market and other conditions; demand for our products; competition, including technological advances made by and new products released by our competitors; our ability to accurately forecast consumer demand for our products and adequately maintain our inventory; and our reliance on a limited number of suppliers and distributors for our products. A further list and descriptions of these risks, uncertainties and other factors can be found in filings with the Securities and Exchange Commission. To the extent permitted under applicable law, the Company assumes no obligation to update any forward-looking statements.

# # #

SOURCE: Interactive Strength Inc.

View the original press release on ACCESS Newswire

TAMPA, FL / ACCESS Newswire / June 25, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare technology company focused on building the future of prescription access and distribution, today announced significant Q2 2025 operational results-adding 116 new pharmaceutical manufacturer partnerships, over 12,400 new products (NDCs), and 275+ pharmacies to its national platform.

This expansion reflects Wellgistics’ accelerating momentum in creating a modern drug ecosystem-one that aims to connect manufacturers directly to pharmacies, providers, employers, and patients through a fully integrated, AI-powered infrastructure designed to streamline fulfillment, reduce costs, and bypass legacy bottlenecks.

“We’re in hyper structural transformation mode,” said Brian Norton, CEO of Wellgistics Health. “Pharma companies are signaling a shift. They want partners who can deliver speed, visibility, and direct access-not more layers of complexity. Every new manufacturer, every new product, and every new pharmacy is helping us rewire how prescriptions move in this country. We’re laying the foundation for real-time, patient-first drug access at national scale.”

As Wellgistics continues to advance toward direct-to-patient care programs, the company intends to leverage its expanding distribution, fulfillment, and pharmacy network to support new models of care-aligning pharmaceutical manufacturers with a streamlined path to market while offering patients faster, more transparent prescription access.

The Wellgistics platform spans the full prescription journey-from wholesale distribution and digital Rx routing to pharmacy dispensing and Hub Services including eligibility, prior authorization, adherence tracking, and patient engagement. With thousands of pharmacies on board and manufacturer demand accelerating, Wellgistics seeks to be a vital infrastructure partner for reshaping prescription drug delivery in the U.S.

About Wellgistics Health

Wellgistics Health (NASDAQ:WGRX) is a healthcare technology company built for the $500B prescription drug market. Our AI-powered, vertically integrated platform connects pharmaceutical manufacturers directly to providers, pharmacies, employers, and patients-managing the full journey from maker to taker. From distribution and digital routing to pharmacy fulfillment and Hub Services, Wellgistics is delivering the infrastructure to power a faster, smarter, and more transparent future in prescription access.

For more information, visit www.wellgisticshealth.com.

Forward-Looking Statements

This press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as “may, “will, “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, Wellgistics Health’s statements regarding Wellgistics Health’s strategy and descriptions of its future operations, prospects, and plans. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from Wellgistics Health’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other risks detailed in our reports and statements filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in Wellgistics Health’s filings with the SEC, which are available for review at www.sec.gov.

For more information, please contact:

Media Contact: media@wellgisticshealth.com
Investor Relations: investors@wellgisticshealth.com

Investor Relations Contact:

Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, NY 10036
Office: (646) 893-5835
Email: info@skylineccg.com

SOURCE: Wellgistics Health, Inc.

View the original press release on ACCESS Newswire

TORONTO, ON / ACCESS Newswire / June 25, 2025 / Electrovaya Inc. (“Electrovaya” or the “Company”) (NASDAQ:ELVA)(TSX:ELVA), a leading lithium-ion battery technology and manufacturing company, today announced that Dr. Raj DasGupta, Electrovaya’s CEO will be participating at the Roth 15th Annual-London Conference, held at the Four Seasons Park Lane in London, UK.

The Company’s participation underscores Electrovaya’s ongoing commitment to active engagement with the global financial community. During the conference, CEO, Raj DasGupta will take part in one-on-one and small group meetings with leading European institutional investors to discuss the Company’s strategic initiatives, technology roadmap, and long-term growth outlook.

Event: ROTH – 15th Annual – London Conference
Date: June 25-26, 2025
Location: Four Seasons Park Lane, London, UK
Format: 1×1 small group meetings – by invitation only

For more information on the ROTH – 15th Annual – London, UK Conference, or to schedule a one-on-one meeting with Electrovaya’s management, please contact your ROTH representative.

Investor and Media Contact:
Jason Roy
VP, Corporate Development and Investor Relations
Electrovaya Inc.
905-855-4618 / jroy@electrovaya.com

About Electrovaya Inc.
Electrovaya Inc. (NASDAQ:ELVA)(TSX:ELVA) is a pioneering leader in the global energy transformation, focused on contributing to the prevention of climate change by supplying safe and long-lasting lithium-ion batteries. The Company has extensive IP and designs, develops and manufactures proprietary lithium-ion batteries and battery systems for energy storage and heavy duty electric vehicles based on its Infinity Battery Technology Platform. This technology offers enhanced safety and industry leading battery longevity. The Company is also developing next generation solid state battery technology at its Labs division. Headquartered in Ontario, Canada, Electrovaya has two operating sites in Canada and has acquired a 52-acre site with a 135,000 square foot manufacturing facility in New York state for its planned gigafactory. To learn more about Electrovaya, please explore www.electrovaya.com.

SOURCE: Electrovaya, Inc.

View the original press release on ACCESS Newswire

Advancement of long lead work programs to support ML Application

HIGHLIGHTS

• Recent Tunkillia OSS confirms large-scale gold project yielding $2.7bn operating cash^[1]

• Barton accelerating key long-lead PFS and Mining Lease Application programs

ADELAIDE, AUSTRALIA / ACCESS Newswire / June 24, 2025 / Barton Gold Holdings Limited (ASX:BGD)(FRA:BGD3)(OTCQB:BGDFF) (Barton or Company) is pleased to announce the start of baseline water monitoring programs for its South Australian Tunkillia Gold Project (Tunkillia), following the recent publication of Tunkillia’s Optimised Scoping Study (OSS).

The Tunkillia OSS identified a compelling large-scale operation with (at an A$5,000/oz gold price): ¹

• average annual production: ~120koz gold and ~250koz silver

• operating free cashflow: A$2.7 billion

• Net Present Value (NPV _7.5% ): A$1.4 billion

• Internal Rate of Return (IRR): 73%

• Payback period: 0.8 years, and

• A ‘Starter’ pit producing ~206koz Au for A$825m operating free cash in the first 13 months

Barton recently announced a $3 million equity accretive placement priced at a ~4% premium to its last traded price, and a ~25% premium to its 20 trading day volume weighted average price (VWAP).^[2] The use of those funds is primarily to accelerate Reserve conversation upgrade drilling for Tunkillia’s ‘Starter Pit. ² Drilling is anticipated to commence during September 2025, and complete by December 2025.

The baseline water monitoring program is another key long-lead feasibility and approvals work program, with a minimum of two years’ worth of baseline water data required prior to start of mining and production. The new Tunkillia water monitoring program will allow Barton to compare new baseline data with historical baseline data collected during prior analyses of the Tunkillia Gold Project.

Commenting on the start of Tunkillia water monitoring, Barton MD Alexander Scanlon said:

“Tunkillia’s Optimised Scoping Study has confirmed a large-scale, competitive gold and silver operation with significant economies of scale offering strong financial and capital leverage to a rapidly evolving gold market.

“During the balance of calendar year 2025 we will focus on key long-lead feasibility and approvals programs for Tunkillia, with the objective to submit a Mining Lease Application prior to the end of calendar year 2026.

“In parallel, we will be completing our studies for ‘Stage 1′ operations leveraging our Central Gawler Mill, with the objective to transition to ‘producer’ status during 2026. This will enable us to generate free cash flows, and use these funds to advance and develop Tunkillia as our ‘Stage 2′ expansion project. This staged approach offers our shareholders a lower-cost, lower-risk and lower-dilution pathway to 150,000ozpa gold production.”

Authorised by the Managing Director of Barton Gold Holdings Limited.

For further information, please contact:

Alexander Scanlon Managing Director a.scanlon@bartongold.com.au +61 425 226 649

Jade Cook Company Secretary cosec@bartongold.com.au +61 8 9322 1587

SOURCE: Barton Gold Holdings Limited

View the original press release on ACCESS Newswire

BOCA RATON, FL / ACCESS Newswire / June 24, 2025 / Greenlane Holdings, Inc. (NASDAQ:GNLN) (“Greenlane”), a global seller of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today announced that it will effect a one-for-seven hundred fifty reverse stock split (the “Reverse Split”) of its Class A common stock, par value $0.01 per share (the “Class A common stock”), that will become effective on June 26, 2025 at 5:00 P.M. Eastern Time, after the closing of trading on The Nasdaq Capital Market (“Nasdaq”). Greenlane has requested that Greenlane’s Class A common stock begin trading on June 27, 2025, on a post-Reverse Split basis on the Nasdaq under the existing symbol “GNLN.”

The Reverse Split is primarily intended to bring Greenlane into compliance with the minimum bid price requirement for maintaining its listing on the Nasdaq. The new CUSIP number for the Class A common stock following the Reverse Split will be 395330509.

At Greenlane’s special meeting of stockholders on June 16, 2025 (the “Special Meeting”), Greenlane’s stockholders approved the proposal to authorize Greenlane’s board of directors (the “Board”), in its sole and absolute discretion, to file a certificate of amendment (the “Amendment”) to Greenlane’s amended and restated certificate of incorporation to effect the Reverse Split at a ratio to be determined by the Board, ranging from one-for-two hundred fifty to one-for-seven hundred fifty. On June 12, 2025, the Board approved the Reverse Split at a ratio of one-for-seven hundred fifty and the Amendment has been filed with the Secretary of State of the State of Delaware, which will become effective on June 26, 2025, at 5:00 P.M. Eastern Time, before the opening of trading on the Nasdaq.

The Reverse Split will affect all issued and outstanding shares of Class A common Stock. All outstanding options, restricted stock awards, warrants and other securities entitling their holders to purchase or otherwise receive shares of Class A common stock will be adjusted as a result of the Reverse Split, as required by the terms of each security. The number of shares available to be awarded under Greenlane’s Third Amended and Restated 2019 Equity Incentive Plan, will also be appropriately adjusted. Following the Reverse Split, the par value of the Class A common stock will remain unchanged at $0.01 per share. The Reverse Split will not change the authorized number of shares of Class A common stock or preferred stock. No fractional shares of Class A Common Stock shall be issued as a result of the Reverse Split, and stockholders who otherwise would be entitled to receive fractional shares of New Class A Common Stock shall be entitled to receive the number of shares of New Class A Common Stock rounded up to the next whole number. The Reverse Split will affect all stockholders uniformly and will not alter any stockholder’s percentage interest in Greenlane’s equity (other than as a result of the rounding of fractional shares, as set forth above).

The Reverse Split will reduce the number of shares of Class A common stock issued and outstanding from approximately 1,039,735,642 million to approximately 1,386,314.

About Greenlane Holdings, Inc.

Founded in 2005, Greenlane is a premier global platform for the development and distribution of premium smoking accessories, vape devices, and lifestyle products to thousands of producers, processors, specialty retailers, smoke shops, convenience stores, and retail consumers. We operate as a powerful family of brands, third-party brand accelerator, and an omnichannel distribution platform.

We proudly offer our own diverse brand portfolio including Higher Standards and Groove, and our exclusively licensed Marley Natural and K.Haring branded products. We also offer a carefully curated set of third-party products such as DaVinci Vaporizers, Storz & Bickel, Eyce, Pax, VIBES, and CCELL through our direct sales channels and our proprietary, owned and operated e-commerce platforms which include Vapor.com, PuffItUp.com, HigherStandards.com, and MarleyNaturalShop.com.

For additional information, please visit: https://investor.gnln.com.

Forward Looking Statements

Certain matters within this press release are discussed using forward-looking language as specified in the Private Securities Litigation Reform Act of 1995, and, as such, may involve known and unknown risks, uncertainties and other factors that may cause the actual results or performance to differ from those projected in the forward-looking statements. These forward-looking statements include, among others, statements relating to: the current and future performance of the Company’s business, the Company’s ability to satisfy the various rules and requirements imposed by The Nasdaq Stock Market, unforeseen technical issues that could result in Greenlane’s Class A common stock not trading on The Nasdaq Stock Market on a post-Reverse Stock split basis on June 27, 2025 as expected and the Company’s financial outlook and expectations. For a description of factors that may cause the Company’s actual results or performance to differ from its forward-looking statements, please review the information under the heading “Risk Factors” included in the Company’s most recent Annual Report on Form 10-K for the year ended December 31, 2024, the Company’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2024, and the Company’s other filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. Undue reliance should not be placed on the forward-looking statements in this press release, which are based on information available to Greenlane on the date hereof. Greenlane undertakes no duty to update this information unless required by law.

Investor Contact:

IR@greenlane.com

or

TraDigital IR
Kevin McGrath
+1-646-418-7002
kevin@tradigitalir.com

SOURCE: Greenlane Holdings, Inc.

View the original press release on ACCESS Newswire